HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deepika Dhawan Selected Research

EC0905

1/2013Targeting folate receptors to treat invasive urinary bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deepika Dhawan Research Topics

Disease

21Neoplasms (Cancer)
01/2023 - 12/2002
14Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 02/2006
12Carcinoma (Carcinomatosis)
01/2022 - 01/2012
5Neoplasm Metastasis (Metastasis)
01/2019 - 01/2013
3Transitional Cell Carcinoma
01/2014 - 05/2009
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2023 - 06/2018
2Lymphoma (Lymphomas)
06/2023 - 02/2014
2Neutropenia
12/2018 - 01/2013
1Autoimmune Diseases (Autoimmune Disease)
01/2023
1Glioma (Gliomas)
01/2023
1Papilloma (Papillomatosis)
11/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
10/2021
1Krause-Kivlin syndrome
10/2021
1Hypertension (High Blood Pressure)
10/2020
1Noncommunicable Diseases
10/2020
1Heart Diseases (Heart Disease)
10/2020
1Abdominal Obesity
10/2020
1Alcoholic Fatty Liver
10/2020
1Kidney Diseases (Kidney Disease)
10/2020
1Thrombocytopenia (Thrombopenia)
06/2018
1Breast Neoplasms (Breast Cancer)
01/2015
1Necrosis
12/2002
1Melanoma (Melanoma, Malignant)
12/2002

Drug/Important Bio-Agent (IBA)

5Phenobarbital (Luminal)FDA Link
01/2022 - 01/2015
4Complement System Proteins (Complement)IBA
11/2021 - 05/2009
3Proteins (Proteins, Gene)FDA Link
01/2023 - 05/2009
3Folic Acid (Vitamin M)FDA LinkGeneric
12/2018 - 01/2013
2RNA (Ribonucleic Acid)IBA
01/2023 - 01/2019
2MicroRNAs (MicroRNA)IBA
01/2022 - 10/2021
2Peptides (Polypeptides)IBA
01/2022 - 01/2016
2Cyclooxygenase InhibitorsIBA
01/2022 - 02/2006
2Epidermal Growth Factor (EGF)IBA
01/2022 - 01/2020
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2010 - 04/2008
2Celecoxib (Celebrex)FDA Link
05/2010 - 04/2008
1Vincristine (Oncovin)FDA LinkGeneric
06/2023
1thymidine kinase 1IBA
06/2023
1Biomarkers (Surrogate Marker)IBA
06/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2023
1Prednisone (Sone)FDA LinkGeneric
06/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1Elastin-Like PolypeptidesIBA
01/2022
1deracoxibIBA
01/2022
1VemurafenibIBA
11/2021
1EnzymesIBA
10/2021
1AdipokinesIBA
10/2020
1anthrax toxin (anthrax lethal factor)IBA
01/2020
1MucinsIBA
01/2020
1Immunotoxins (Immunotoxin)IBA
01/2020
1Immune Checkpoint ProteinsIBA
01/2019
1EC0531IBA
12/2018
1LipidsIBA
07/2018
1Fatty Acids (Saturated Fatty Acids)IBA
07/2018
1Messenger RNA (mRNA)IBA
06/2018
1ClaudinsIBA
01/2018
1ferric oxide (iron oxide)IBA
01/2016
1glycol-chitosanIBA
01/2016
11,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA
01/2015
1AntibodiesIBA
02/2014
1EC0905IBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
01/2012
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2010
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2008
1Pentamidine (NebuPent)FDA LinkGeneric
12/2002
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2002

Therapy/Procedure

15Therapeutics
01/2023 - 12/2002
3Drug Therapy (Chemotherapy)
06/2023 - 02/2014
3Immunotherapy
01/2023 - 01/2017
1Traction
01/2023
1Cystectomy
05/2010